Master the board step 3

Master the Boards: USMLE Step 3
Subdural hemorrhage, 491
Substance abuse/disorders,
522–27
neonatal withdrawal, 371–73
Sudan black stain, 201
Suicide and suicidal ideation, 496,
509
Sulfonamides, in neonate, 372
Sulfonylureas, 90–91
Supraventricular tachycardia
(SVT), 84
Surface antigen, 215
Surfactant mechanism, 360
Swan-Ganz catheterization, 129
Swan neck deformity, 136
Synchronization
electrical cardioversion,
82–84, 86
pulmonary edema
management, 63
Syncope
evaluation, 87–88
mechanisms, 71
Syndrome of inappropriate ADH
release (SIADH), 265–66
Synovial fluid count, 153
Syphilis, 22–23, 301
cold-induced hemolysis, 169
in newborn, 369
in pregnancy, 431
prenatal screening, 418
stages, 22–23
Syringomyelia, 245
Systemic lupus erythematosus
(SLE), 142–44
nephritis, 260
Systemic sclerosis, 145–46
Systolic function, 60, 72
murmurs, 67
T
T4 levels
Takayasu’s arteritis, 152
Tamoxifen, 278–79, 459–60
Tardive dyskinesia, 499–500
Tarsal tunnel syndrome, 157
Taste receptors, 191
Telaprevir, 217
Telavancin, 3
Telemetry monitoring, 82, 84
Temporal arteritis, 151–52, 234
Temporal lobe epilepsy, 496
Tension pneumothorax, 310, 332
Testicular cancer, 282
Testicular feminization, 111
Testicular torsion, 345
Tetralogy of Fallot, 388, 390
Thalamic hemorrhage, 492
Thallium testing, mechanisms of,
50–51
Thiamine, 530
Thiazolidinediones, 91
Thoracic aorta dissection, 81
Thoracic aortic aneurysm, 349
Thrombocytopenia
essential thrombocytopenia,
178
gestational, 435
Thrombolytics
acute coronary syndrome, 52
myocardial infarction, 56
pulmonary embolism, 125
stroke management, 225
Thrombophilia, 186, 437
Thromboplastin, 442
Thrombopoietin analogs, 183
Thrombosis, heparin-induced
thrombocytopenia, 185
Thrombotic thrombocytopenic
purpura (TTP), 171–72, 260–61
Thyroglossal duct cyst, 356–57
Thyroid disease, 96–100
goiter, 99–100
hyperthyroidism, 96–99
hypothyroidism, 96
in pregnancy, 438
solitary thyroid nodule, 100
Thyroid hormone, 96–97
Thyroid nodule, solitary, 100
Thyroid-stimulating hormone
(TSH), 96
Thyroid “storm,” 99
Thyroxine replacement, 96–97
Ticagrelor, 51–54
Tick-borne diseases, 34–36
Tinel’s sign, 340
Tinnitus, 532
TMP-SMX antagonist, 3
TORCH infections, 369
Torsade de pointes, 86
Tourette syndrome, 497
Toxic epidermal necrolysis,
293–94
Toxic megacolon, 491
Toxic shock syndrome (TSS), 303
Toxin-induced renal insufficiency,
253
Toxin-mediated diseases, 303–4
Toxoplasmosis, 32, 369, 426–27
Tracheoesophageal fistula (TEF),
362–63
Transesophageal echocardiogram
(TEE), 70, 72, 74, 80
Transfusion reactions, 173–74
Transient ischemic attack (TIA),
223–26
Transient tachypnea of the
newborn (TTN), 360–61
Transjugular intrahepatic
portosystemic shunt (TIPS),
209
Transposition of great arteries,
390
Transsexualism, 527–28
Transthoracic echocardiography
(TTE), 70, 72, 74, 84
Trastuzumab, 279
Trauma, 309–16
abdominal, 311
airway management, 309
breathing management,
309–10
chest, 310
circulation, 310
head trauma, 312–16
localized sites, 312
psychiatric disorders, 504–5
566